Compounds > 2-methoxy-N-[(4-methylphenyl)methyl]-2-phenylacetamide
Page last updated: 2024-07-31 21:38:26
2-methoxy-N-[(4-methylphenyl)methyl]-2-phenylacetamide
Description
2-methoxy-N-[(4-methylphenyl)methyl]-2-phenylacetamide : no description available [CHeBI]
Cross-References
Synonyms (16)
Synonym |
OPREA1_260397 |
HMS2598E10 |
MLS000687192 |
smr000284067 |
TIMTEC1_007273 |
OPREA1_410339 |
CHEBI:108336 |
HMS1554K13 |
AKOS000594751 |
2-methoxy-n-[(4-methylphenyl)methyl]-2-phenylacetamide |
2-methoxy-n-(4-methylbenzyl)-2-phenylacetamide |
STL120871 |
AKOS025262556 |
CHEMBL1423209 |
cambridge id 6394133 |
Q27187075 |
Drug Classes (1)
Class | Description |
acetamides | Compounds with the general formula RNHC(=O)CH3. |
Protein Targets (2)
Potency Measurements
Bioassays (10)
Assay ID | Title | Year | Journal | Article |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13ISSN: 1934-9300 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 ISSN: 1552-4922 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 ISSN: 1557-8127 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13ISSN: 1934-9300 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 ISSN: 1552-4922 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 ISSN: 1557-8127 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | 2022 | The Journal of biological chemistry, 08, Volume: 298, Issue:8 ISSN: 1083-351X | |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13ISSN: 1934-9300 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 ISSN: 1552-4922 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 ISSN: 1557-8127 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7 ISSN: 1945-7170 | A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7 ISSN: 1945-7170 | A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
AID588519 | A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities | 2011 | Antiviral research, Sep, Volume: 91, Issue:3 ISSN: 1872-9096 | High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors. |
AID540299 | A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis | 2010 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21 ISSN: 1464-3405 | Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. |
AID1159537 | qHTS screening for TAG (triacylglycerol) accumulators in algae | 2017 | Plant physiology, Aug, Volume: 174, Issue:4 ISSN: 1532-2548 | Identification and Metabolite Profiling of Chemical Activators of Lipid Accumulation in Green Algae. |
AID1794808 | Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL). | 2014 | Journal of biomolecular screening, Jul, Volume: 19, Issue:6 ISSN: 1552-454X | A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum. |
AID1794808 | Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL). | 2022 | Journal of enzyme inhibition and medicinal chemistry, Dec, Volume: 37, Issue:1 ISSN: 1475-6374 | |
Research
Studies (10)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (10.00) | 29.6817 |
2010's | 7 (70.00) | 24.3611 |
2020's | 2 (20.00) | 2.80 |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 10 (100.00%) | 84.16% |
Substance | Studies | Classes | Roles | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
acetamide | | acetamides; carboximidic acid; monocarboxylic acid amide; N-acylammonia | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
melatonin | | acetamides; tryptamines | anticonvulsant; central nervous system depressant; geroprotector; hormone; human metabolite; immunological adjuvant; mouse metabolite; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-acetylserotonin | | acetamides; N-acylserotonin; phenols | antioxidant; human metabolite; mouse metabolite; tropomyosin-related kinase B receptor agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acetanilide | | acetamides; anilide | analgesic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n'-acetylspermine | | acetamides; acetylspermine | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-chloromelatonin | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-hydroxymelatonin | | acetamides; tryptamines | metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acetaminophen | | acetamides; phenols | antipyretic; cyclooxygenase 1 inhibitor; cyclooxygenase 2 inhibitor; cyclooxygenase 3 inhibitor; environmental contaminant; ferroptosis inducer; geroprotector; hepatotoxic agent; human blood serum metabolite; non-narcotic analgesic; non-steroidal anti-inflammatory drug; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acetarsol | | acetamides; anilide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-(acetylamino)benzeneacetic acid | | acetamides; anilide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
diatrizoic acid | | acetamides; benzoic acids; organoiodine compound | environmental contaminant; radioopaque medium; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ci 994 | | acetamides; benzamides; substituted aniline | antineoplastic agent; EC 3.5.1.98 (histone deacetylase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
colchicine, (+-)-isomer | | acetamides; alkaloid; aromatic ether; carbotricyclic compound | microtubule-destabilising agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gr 89696 | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
guanfacine | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hexamethylene bisacetamide | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acecainide | | acetamides; benzamides | anti-arrhythmia drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phenacemide | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phenacetin | | acetamides; aromatic ether | cyclooxygenase 3 inhibitor; non-narcotic analgesic; peripheral nervous system drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
practolol | | acetamides; ethanolamines; propanolamine; secondary alcohol; secondary amino compound | anti-arrhythmia drug; beta-adrenergic antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tropicamide | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
talactoferrin alfa | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methacetin | | acetamides; aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acedapsone | | acetamides; anilide; secondary carboxamide; sulfone | antimalarial; antimicrobial drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-methylacetamide | | acetamides; monocarboxylic acid amide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acetopyrrothine | | acetamides; dithiolopyrrolone antibiotic | angiogenesis inhibitor; antibacterial agent; antifungal agent; antineoplastic agent; bacterial metabolite; chelator; EC 2.7.7.6 (RNA polymerase) inhibitor; marine metabolite; protein synthesis inhibitor; toxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phenylbutyramide | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(2-methoxyphenyl)acetamide | | acetamides; methoxybenzenes | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-methylacetanilide | | acetamides; toluenes | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
arsthinol | | acetamides; anilide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nithiamide | | acetamides; aromatic amide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4'-(chloroacetyl)acetanilide | | acetamides; alpha-chloroketone; aromatic ketone | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-chloroacetanilide | | acetamides; monochlorobenzenes | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
monoacetyldapsone | | acetamides; anilide; secondary carboxamide; sulfone | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-hydroxyacetanilide | | acetamides; phenols | anti-inflammatory agent; antineoplastic agent; antirheumatic drug; apoptosis inducer; platelet aggregation inhibitor; xenobiotic metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-hydroxyacetanilide | | acetamides; phenols | non-narcotic analgesic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-ethylacetamide | | acetamides | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ethyl n-alpha-acetyl-tyrosinate | | acetamides; ethyl ester; L-tyrosine derivative; phenols | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-acetamidoethanethiol | | acetamides | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n,n-diethylphenylacetamide | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
trimethylcolchicinic acid methyl ether | | acetamides; alkaloid; carbotricyclic compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dimethylacetamide | | acetamides; monocarboxylic acid amide | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-acetylaminofluorene | | acetamides; fluorenes | mitogen | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ioxitalamic acid | | acetamides; benzoic acids; dicarboxylic acid monoamide; organoiodine compound | environmental contaminant; radioopaque medium; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lorcainide | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bidisomide | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n(4)-acetylsulfadiazine | | acetamides; pyrimidines; sulfonamide | marine xenobiotic metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
oseltamivir | | acetamides; amino acid ester; cyclohexenecarboxylate ester; primary amino compound | antiviral drug; EC 3.2.1.18 (exo-alpha-sialidase) inhibitor; environmental contaminant; prodrug; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-sulfatoxymelatonin | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-acetylaminoantipyrine | | acetamides; pyrazoles | drug metabolite; marine xenobiotic metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
milnacipran | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N(4)-acetylsulfathiazole | | 1,3-thiazoles; acetamides; sulfonamide | marine xenobiotic metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
disobutamide | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
glycolamide | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-acetylhistamine | | acetamides; imidazoles | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-acetyltryptamine | | acetamides; indoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acamprosate | | acetamides; organosulfonic acid | environmental contaminant; neurotransmitter agent; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
guanfacine hydrochloride | | acetamides | geroprotector | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
epanolol | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-Acetylhomoveratrylamine | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
s20098 | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acetaminophen sulfate ester | | acetamides; aryl sulfate | drug metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acetaminophen mercapturate | | acetamides; organic sulfide; phenols; S-substituted N-acetyl-L-cysteine | drug metabolite; human urinary metabolite; rat metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-(hydroxyphenyl)acetamide | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-acetyltryptophanamide | | acetamides; L-tryptophan derivative; primary carboxamide; secondary carboxamide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-acetyldopamine | | acetamides; catechols; N-(fatty acyl)-dopamine; secondary carboxamide | human urinary metabolite; marine metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ethyl-3-(n-n-butyl-n-acetyl)aminopropionate | | acetamides; ethyl ester; tertiary carboxamide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-acetylcytidine | | acetamides; cytidines; secondary carboxamide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-iodomelatonin | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-acetyltyramine | | acetamides; tyramines | animal metabolite; Aspergillus metabolite; bacterial metabolite; marine metabolite; quorum sensing inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
luzindole | | acetamides; indoles | melatonin receptor antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acetylphenylalanyl-prolyl-boroarginine | | acetamides; C-terminal boronic acid peptide; guanidines | anticoagulant; EC 3.4.21.5 (thrombin) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n',n''-diacetylspermine | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bcx 1812 | | 3-hydroxy monocarboxylic acid; acetamides; cyclopentanols; guanidines | antiviral drug; EC 3.2.1.18 (exo-alpha-sialidase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acetyltaurine | | acetamides; organosulfonic acid | human blood serum metabolite; human urinary metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
milnacipran hydrochloride | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n(4)-acetylsulfadimethoxine | | acetamides; pyrimidines; sulfonamide | marine xenobiotic metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
monoacetylcadaverine | | acetamides; N-substituted cadaverine; primary amino compound; secondary carboxamide | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-hydroxy-2-phenylacetamide | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(1-phenylethyl)acetamide | | acetamides; secondary carboxamide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gamma-lumicolchicine | | acetamides; alkaloid; carbotricyclic compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(1-oxo-2-phenylethyl)-4-piperidinecarboxylic acid | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
mr 16728 | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
linezolid | | acetamides; morpholines; organofluorine compound; oxazolidinone | antibacterial drug; protein synthesis inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ammodendrine | | acetamides; N-acylpiperidine; piperidine alkaloid | plant metabolite; teratogenic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
laninamivir | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[2-(4-methoxyphenyl)ethyl]acetamide | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(4-acetamidophenyl)-2-[(5-cyclopropyl-4-ethyl-1,2,4-triazol-3-yl)thio]acetamide | | acetamides; anilide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(4-{[2-(pyridin-3-yl)piperidin-1-yl]sulfonyl}phenyl)acetamide | | acetamides; piperidines; pyridines; sulfonamide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(4-methoxyphenyl)-N-(phenylmethyl)-N-propan-2-ylacetamide | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[4-(4-morpholinylazo)phenyl]acetamide | | acetamides; anilide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[[6-cyano-5-(ethylamino)-3-methyl-2-pyrazinyl]methyl]-N-phenylacetamide | | acetamides; anilide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[4-(5-bromo-2-thiophenyl)-2-thiazolyl]acetamide | | acetamides; aromatic amide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(1-azepanyl)-2-(4-bromophenyl)ethanone | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-(2-nitrophenyl)acetamide | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(5-chloro-2-hydroxyphenyl)-2-(4-methoxyphenyl)acetamide | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[3-(methylthio)-1,2,4-thiadiazol-5-yl]-2-phenylacetamide | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(3-acetamidophenoxy)-N-phenylacetamide | | acetamides; anilide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(4-methoxyphenyl)-N-(1,3,4-thiadiazol-2-yl)-1-cyclopentanecarboxamide | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[4-[2-[(4-methyl-2-pyridinyl)amino]-4-thiazolyl]phenyl]acetamide | | acetamides; anilide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[4-[2-[(6-methyl-2-pyridinyl)amino]-4-thiazolyl]phenyl]acetamide | | acetamides; anilide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[3-[2-[(4-methyl-2-pyridinyl)amino]-4-thiazolyl]phenyl]acetamide | | acetamides; anilide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-[[2-(3-bromo-4-methoxyphenyl)-1-oxoethyl]amino]-3-phenylthiourea | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-(2,4-dichlorophenyl)-2-[(1-oxo-2-phenylethyl)amino]-3-thiophenecarboxamide | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-acetamido-5-propyl-3-thiophenecarboxamide | | acetamides; aromatic amide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(4-methoxyphenyl)-N-[4-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]phenyl]acetamide | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(4-bromophenyl)-N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)acetamide | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[4-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]phenyl]-2-(2-methoxyphenyl)acetamide | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(4-chlorophenyl)-N-[4-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]phenyl]acetamide | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-ethyl-3-[(1-oxo-2-phenylethyl)amino]thiourea | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[4-[[2-[1-(2-methoxyethyl)-2,5-dimethyl-3-pyrrolyl]-2-oxoethyl]thio]phenyl]acetamide | | acetamides; anilide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-phenyl-N-[2-(phenylmethylthio)ethyl]acetamide | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[2-(4-tert-butylphenoxy)ethyl]-2-(4-fluorophenyl)acetamide | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(4-chlorophenyl)-N-[4-(difluoromethylthio)phenyl]acetamide | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(4-acetamidophenyl)-2-[5-(1-piperidinylsulfonyl)-2-thiophenyl]acetamide | | acetamides; anilide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[4-[(2-furanylmethylamino)-sulfanylidenemethyl]phenyl]acetamide | | acetamides; anilide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acetylthiourea | | acetamides; thioureas | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
alpha-acetyllysine methyl ester | | acetamides; alpha-amino acid ester; L-lysine derivative; methyl ester; primary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(2,6-dimethyl-1-piperidinyl)-2-phenylethanone | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(2-methoxyphenyl)-2-phenyl-2-(phenylthio)acetamide | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ici 199441 | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[4-[[2-(4-acetamidoanilino)-5-nitro-4-pyrimidinyl]amino]phenyl]acetamide | | acetamides; anilide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-[5-hydroxy-3-methyl-5-(3-pyridinyl)-4H-pyrazol-1-yl]-2-(4-methylphenyl)ethanone | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
CID 3191469 | | acetamides; anilide | anticoronaviral agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
CID 3198732 | | acetamides; anilide | anticoronaviral agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(4-ethoxyphenyl)-1-[5-hydroxy-3-methyl-5-(trifluoromethyl)-4H-pyrazol-1-yl]ethanone | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-methoxycarbonylamino-n-acetyltryptamine | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(4-chlorophenyl)-3-methyl-N-(2-thiazolyl)butanamide | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[2-[1-(3,5-dimethyl-1-piperidinyl)-1-oxopropan-2-yl]oxyphenyl]acetamide | | acetamides; anilide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
brl 52537 | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,4-dichloro-n-methyl-n-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide, (trans)-(-)-isomer | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
levomilnacipran | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
andarine | | acetamides; anilide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ro-28-1675 | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
holomycin | | acetamides; dithiolopyrrolone antibiotic | antibacterial agent; antineoplastic agent; bacterial metabolite; chelator; EC 2.7.7.6 (RNA polymerase) inhibitor; marine metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[1-(5,6-dicyano-3-methyl-2-pyrazinyl)ethyl]-N-phenylacetamide | | acetamides; anilide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
milnacipran | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
trametinib | | acetamides; aromatic amine; cyclopropanes; organofluorine compound; organoiodine compound; pyridopyrimidine; ring assembly | anticoronaviral agent; antineoplastic agent; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor; geroprotector | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-(3-fluorophenyl)-1-((4-(((3s)-3-methyl-1-piperazinyl)methyl)phenyl)acetyl)-4-piperidinamine | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-acetamidoglucal | | acetamides; glycal derivative | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-[1-[[1-(4-methoxyphenyl)cyclopropyl]-oxomethyl]-4-piperidinyl]-5-phenyl-1,3,4-oxadiazol-2-one | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-[1-[[1-(4-methylphenyl)cyclopropyl]-oxomethyl]-4-piperidinyl]-5-phenyl-1,3,4-oxadiazol-2-one | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-[1-[oxo-(1-phenylcyclopropyl)methyl]-4-piperidinyl]-5-phenyl-1,3,4-oxadiazol-2-one | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-[1-[[1-(4-chlorophenyl)cyclopropyl]-oxomethyl]-4-piperidinyl]-5-phenyl-1,3,4-oxadiazol-2-one | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n(alpha)-acetylfusarinines | | 2,5-diketopiperazines; acetamides; carboxylic ester; homoallylic alcohol; hydroxamic acid; primary alcohol | siderophore | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[2-[[4-(2-hydroxyethylamino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]phenyl]acetamide | | acetamides; anilide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[5-[[2-(4-acetamidoanilino)-2-oxoethyl]thio]-1,3,4-thiadiazol-2-yl]-3-methoxybenzamide | | acetamides; anilide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[5-[[2-(4-acetamidoanilino)-2-oxoethyl]thio]-1,3,4-thiadiazol-2-yl]-5-bromo-2-furancarboxamide | | acetamides; anilide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[(2S,3S)-2-[[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-phenylacetamide | | acetamides | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
KOM70144 | | acetamides; benzamides; naphthalenes; secondary carboxamide | anticoronaviral agent; protease inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-(2-(5-methoxy-2-oxo-2,3-dihydro-1h-indol-3-yl)ethyl)acetamide | | acetamides; hydroxyindoles; tryptamines | antineoplastic agent; apoptosis inducer; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[4-[2-(2-methoxyethylamino)-6H-1,3,4-thiadiazin-5-yl]phenyl]acetamide | | acetamides; anilide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[4-[2-(2-oxolanylmethylamino)-6H-1,3,4-thiadiazin-5-yl]phenyl]acetamide | | acetamides; anilide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
Substance | Studies | Classes | Roles | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
levoplast | | C-nitro compound | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
hippuric acid | | N-acylglycine | human blood serum metabolite; uremic toxin | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
xanthine | | xanthine | Saccharomyces cerevisiae metabolite | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
atrolactic acid | | 2-hydroxy monocarboxylic acid | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
etofylline | | oxopurine | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
n-acetyltryptophan | | N-acetyl-amino acid; tryptophan derivative | metabolite | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
ethacridine | | acridines | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
altretamine | | triamino-1,3,5-triazine | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
2,5-di-tert-butylhydroquinone | | hydroquinones | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
cx546 | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
diphenhydramine | | ether; tertiary amino compound | anti-allergic agent; antidyskinesia agent; antiemetic; antiparkinson drug; antipruritic drug; antitussive; H1-receptor antagonist; local anaesthetic; muscarinic antagonist; oneirogen; sedative | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
diuron | | 3-(3,4-substituted-phenyl)-1,1-dimethylurea; dichlorobenzene | environmental contaminant; mitochondrial respiratory-chain inhibitor; photosystem-II inhibitor; urea herbicide; xenobiotic | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
ibuprofen | | monocarboxylic acid | antipyretic; cyclooxygenase 1 inhibitor; cyclooxygenase 2 inhibitor; drug allergen; environmental contaminant; geroprotector; non-narcotic analgesic; non-steroidal anti-inflammatory drug; radical scavenger; xenobiotic | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
ipriflavone | | aromatic ether; isoflavones | bone density conservation agent | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
mebendazole | | aromatic ketone; benzimidazoles; carbamate ester | antinematodal drug; microtubule-destabilising agent; tubulin modulator | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
nocodazole | | aromatic ketone; benzimidazoles; carbamate ester; thiophenes | antimitotic; antineoplastic agent; microtubule-destabilising agent; tubulin modulator | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
piribedil | | N-arylpiperazine | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
procainamide | | benzamides | anti-arrhythmia drug; platelet aggregation inhibitor; sodium channel blocker | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
prometone | | diamino-1,3,5-triazine; methoxy-1,3,5-triazine | environmental contaminant; herbicide; xenobiotic | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
propanil | | anilide; dichlorobenzene | herbicide | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
sulfadimethoxine | | aromatic ether; pyrimidines; substituted aniline; sulfonamide antibiotic; sulfonamide | antiinfective agent; antimicrobial agent; drug allergen; environmental contaminant; xenobiotic | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
sulfamethazine | | pyrimidines; sulfonamide antibiotic; sulfonamide | antibacterial drug; antiinfective agent; antimicrobial agent; carcinogenic agent; drug allergen; EC 2.5.1.15 (dihydropteroate synthase) inhibitor; environmental contaminant; ligand; xenobiotic | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
sulfathiazole | | 1,3-thiazoles; substituted aniline; sulfonamide antibiotic; sulfonamide | antiinfective agent; drug allergen; EC 2.5.1.15 (dihydropteroate synthase) inhibitor; environmental contaminant; xenobiotic | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
testosterone | | 3-hydroxy steroid | androgen | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-hydroxybenzylbenzimidazole | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
etimizol | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
nifenalol | | C-nitro compound | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
bis(4-hydroxyphenyl)sulfone | | bisphenol; sulfone | endocrine disruptor; metabolite | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
8-hydroxyquinoline-5-sulfonic acid | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
salicylanilide | | benzanilide fungicide; salicylamides; salicylanilides | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
2-phenylbutyric acid | | benzenes; monocarboxylic acid | human xenobiotic metabolite | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
4,4'-dimethoxybenzophenone | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
6-phenyl-1,3,5-triazine-2,4-diamine | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
quinaldic acid | | quinolinemonocarboxylic acid | human metabolite; Saccharomyces cerevisiae metabolite | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
N-(2-methoxyphenyl)acetamide | | acetamides; methoxybenzenes | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
fast red b | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
methylenebis(chloroaniline) | | chloroaniline | metabolite | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
di-(4-aminophenyl)ether | | aromatic ether | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
diphenylguanidine | | guanidines | allergen | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
4-Anilino-4-oxobutanoic acid | | anilide | | 2017 | 2017 | 7.0 | high | 0 | 0 | 0 | 0 | 1 | 0 |
mephobarbital | | barbiturates | anticonvulsant | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
etryptamine | | indoles | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
sulfacetamide | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
cinchophen | | quinolines | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
2-aminobenzothiazole | | benzothiazoles | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
carzenide | | sulfonamide | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
nitrilotriacetic acid | | NTA; tricarboxylic acid | carcinogenic agent; nephrotoxic agent | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
n-(2-cyanoethyl)-2-phenylethylamine | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
cyclooctane | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
triphenyltetrazolium chloride | | organic chloride salt | dye; indicator | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2,7-diacetylaminofluorene | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
3,4-pyridinedicarboxylic acid | | pyridinedicarboxylic acid | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
4-(benzoylamino)-2-hydroxybenzoic acid | | benzamides | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
tropic acid | | 3-hydroxy monocarboxylic acid | human xenobiotic metabolite | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
8-hydroxy-7-iodo-5-quinolinesulfonic acid | | hydroxyquinoline | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
1-acetylisatin | | indoledione | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
4-cumylphenol | | diarylmethane | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
5-methylisatin | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
2-hydrazinobenzothiazole | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
1,2,3-trimethoxybenzene | | methoxybenzenes | plant metabolite | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
2-amino-5-chlorobenzophenone | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
diphenamid | | diarylmethane | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
4-(4-nitrobenzyl)pyridine | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
5-methyl-3-phenylisoxazole-4-carboxylic acid | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-acetylbenzofuran | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
pyrazon | | benzenes; organochlorine compound; primary amino compound; pyridazinone | environmental contaminant; herbicide; xenobiotic | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
2-amino-5-nitrobenzophenone | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
(4-tert-Butyl-phenoxy)-acetic acid | | monocarboxylic acid | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
lenacil | | cyclopentapyrimidine | agrochemical; environmental contaminant; herbicide; xenobiotic | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
chlordesmethyldiazepam | | benzodiazepine | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
2-amino-2',5-dichlorobenzophenone | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-(2'-hydroxyphenyl)benzimidazole | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
4-phthalimidobutyric acid | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
azabutyrone | | | | 2017 | 2017 | 7.0 | high | 0 | 0 | 0 | 0 | 1 | 0 |
2-(2-hydroxyphenyl)benzothiazole | | benzothiazoles; phenols | geroprotector | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
4,5-dichlorocatechol | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
n-butylbenzenesulfonamide | | sulfonamide | neurotoxin; plant metabolite | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
3-phenoxybenzoic acid | | phenoxybenzoic acid | human xenobiotic metabolite; marine xenobiotic metabolite | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
2-(2-hydroxyethylmercapto)benzothiazole | | | | 2017 | 2017 | 7.0 | high | 0 | 0 | 0 | 0 | 1 | 0 |
carboxin | | anilide fungicide; anilide; enamide; organosulfur heterocyclic compound; oxacycle; secondary carboxamide | antifungal agrochemical; EC 1.3.5.1 [succinate dehydrogenase (quinone)] inhibitor | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
meturin | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-bromo-N-phenylbenzamide | | benzamides | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
4-chlorohippuric acid | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
4-chlorophenoxyacetic acid | | chlorophenoxyacetic acid; monochlorobenzenes | phenoxy herbicide | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
2,5-dichloro-1,4-phenylenediamine | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
metribuzin | | 1,2,4-triazines; cyclic ketone; organic sulfide | agrochemical; environmental contaminant; herbicide; xenobiotic | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
2,5-dimethyl-3-furancarboxanilide | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
moricizine hydrochloride | | hydrochloride | anti-arrhythmia drug | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
2-benzimidazolylguanidine | | aminoimidazole | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
diflubenzuron | | benzoylurea insecticide; monochlorobenzenes | insect sterilant | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
pentafluorobenzoyl-n-phenylethylamine | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
thidiazuron | | ureas | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
phenthiazamine | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
5,5-diphenylbarbituric acid | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
3-acetamidobenzoic acid | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
dazoxiben hydrochloride | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
succinylsulfanilamide | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
benzylaminopurine | | 6-aminopurines | cytokinin; plant metabolite | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
ciprofloxacin hydrochloride anhydrous | | hydrochloride | antibacterial drug; antiinfective agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; topoisomerase IV inhibitor | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
src-820 r | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
n(4)-acetylsulfadiazine | | acetamides; pyrimidines; sulfonamide | marine xenobiotic metabolite | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
4-nitro-alpha-acetylamino-beta-hydroxypropiophenone | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
formetamide | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
isbufylline | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
phenylacetylglycine | | monocarboxylic acid amide; monocarboxylic acid; N-acylglycine | human metabolite; mouse metabolite | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
N-benzoylanthranilic acid | | amidobenzoic acid | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
butinoline | | diarylmethane | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
n-(2-carboxyphenyl)glycine | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
n,n-dimethyl-4-anisidine | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
n-benzoylpiperidine | | benzamides; N-acylpiperidine | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
2-phenylcyclopropanecarboxylic acid | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
n-demethylantipyrine | | pyrazoles; ring assembly | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
3-(2-pyridyl)-5,6-diphenyl-1,2,4-triazine | | 1,2,4-triazines | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
2-amino-5-bromopyridine | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
n-benzoylalanine, (dl-ala)-isomer | | alanine derivative; N-acyl-amino acid | metabolite | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
bicinchoninic acid | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
betamipron | | organonitrogen compound; organooxygen compound | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
benzoylpropionic acid | | 4-oxo monocarboxylic acid | hapten | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Evoxine | | organic heterotricyclic compound; organonitrogen heterocyclic compound; oxacycle | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
1-methyl-1,2,3,4-tetrahydro-beta-carboline-3-carboxylic acid | | harmala alkaloid | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
N-Benzylphthalimide | | isoindoles | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
pyromellitic diimide | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
4'-bromosalicylanilide | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane | | bisphenol | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
terephthalamide | | benzenedicarboxamide | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
3(2h)-pyridazinone, 4-chloro-5-(dimethylamino)-2-phenyl- | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
2-nitrophenylacetic acid | | C-nitro compound; phenylacetic acids | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
onychine | | | | 2017 | 2017 | 7.0 | high | 0 | 0 | 0 | 0 | 1 | 0 |
4'-methoxyflavone | | ether; flavonoids | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
1,3-diphenyl-2-aminopropane | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2,2-diphenylpropionic acid | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
3,4-dimethoxyphenylacetamide | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-amino-5-bromobenzoic acid | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
2-(1H-benzimidazol-2-yl)aniline | | benzimidazoles; primary arylamine; substituted aniline | geroprotector | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-Acetylhomoveratrylamine | | acetamides | | 2017 | 2017 | 7.0 | high | 0 | 0 | 0 | 0 | 1 | 0 |
2-chlorobenzenesulfonamide | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
4-nitrophenyl dimethylcarbamate | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
8-(4-tolylsulfonylamino)quinoline | | sulfonamide | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
5-methoxyindole-3-carbaldehyde | | indoles | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-oxo-1,2-dihydroquinoline-4-carboxylic acid | | quinolinemonocarboxylic acid | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
6-methoxy-2,3,4,9-tetrahydropyrido[3,4-b]indol-1-one | | beta-carbolines | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
pd 147953 | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
fenozan | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
5-phenylbarbituric acid | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
diethylpropion hydrochloride | | hydrochloride | appetite depressant | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
1-(4'-nitrophenyl)-2-aminopropane-1,3-diol | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
beta-hydroxyphenylalanine | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
3-(n-salicyloyl)amino-1,2,4-triazole | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
7-chloro-4-aminoquinoline | | aminoquinoline | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
acridine-9-carboxylic acid | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1-phenazinecarboxylic acid | | aromatic carboxylic acid; monocarboxylic acid; phenazines | antifungal agent; antimicrobial agent; bacterial metabolite | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
4,5-diphenyl-1,5-dihydroimidazol-2-one | | stilbenoid | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-hydroxy-1,2-bis(methoxyphenyl)ethanone | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
4-methyl-N-(phenylmethyl)benzenesulfonamide | | sulfonamide | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
4-n-butylaminobenzoic acid | | aromatic amino acid | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
fluoren-9-ol | | | | 2017 | 2017 | 7.0 | high | 0 | 0 | 0 | 0 | 1 | 0 |
1-(2-carboxyethyl)uracil | | | | 2017 | 2017 | 7.0 | high | 0 | 0 | 0 | 0 | 1 | 0 |
1-benzylindole | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
2,3-bis(2-pyridinyl)quinoxaline | | quinoxaline derivative | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
3,3',5,5'-tetrachlorobiphenyl-4,4'-diol | | dichlorobenzene; hydroxybiphenyls | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
5-nitro-2-(1-piperidinyl)pyridine | | C-nitro compound | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-amino-5,7-dimethyl-1,8-naphthyridine | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
5-benzyloxytryptophan | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
2,5-diethoxy-4-morpholinoaniline | | | | 2017 | 2017 | 7.0 | high | 0 | 0 | 0 | 0 | 1 | 0 |
3-hydroxy-3-phenacyloxindole | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
carbobenzoxyphenylalanine, (dl-phe)-isomer | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
gamma-fagarine | | organic heterotricyclic compound; organonitrogen heterocyclic compound; oxacycle | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
3-carboxymethyl-6-benzyl-2,5-diketopiperazine | | organonitrogen compound; organooxygen compound | | 2017 | 2017 | 7.0 | high | 0 | 0 | 0 | 0 | 1 | 0 |
4-fluorobenzenesulfonamide | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
emoxypine succinate | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
n-carbamyltryptophan | | | | 2017 | 2017 | 7.0 | high | 0 | 0 | 0 | 0 | 1 | 0 |
2,4,6-trimethoxyacetophenone | | | | 2017 | 2017 | 7.0 | high | 0 | 0 | 0 | 0 | 1 | 0 |
1-(2-hydroxyethyl)-3,5-diphenyl-1h-pyrazole | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
4-methyoxybenzoyl-n-glycine | | N-acylglycine | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
5-ethoxy-2-ethylmercaptobenzimidazole | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
5(6)-1(2h)-phthalazinonyl-4(1h)-benzimidazole-2-carbamate methyl ester | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
n-phenyliminodiacetic acid | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
teomorfolin | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1-(1,3-benzodioxol-5-yl)-3-(1-piperidinyl)-1-propanone | | benzodioxoles | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
n-(aminocarbonyl)-2-chlorobenzenesulfonamide | | | | 2017 | 2017 | 7.0 | high | 0 | 0 | 0 | 0 | 1 | 0 |
3-hydroxy-2-quinoxalinepropionic acid | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
8-(methylsulfonylamino)quinoline | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
n(4)-acetylsulfamonomethoxine | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
8-(4-benzenesulfonylamino)quinoline | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
methindione | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
3,4-dihydroxybenzophenone | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
gamma-propanol | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-[(3-oxo-1-cyclohexenyl)amino]benzonitrile | | benzenes; nitrile | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
isonicotinylamide gaba | | | | 2017 | 2017 | 7.0 | high | 0 | 0 | 0 | 0 | 1 | 0 |
5-fluorotryptamine monohydrochloride | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
4-iodo-n-(2-(4-morpholinyl)ethyl)benzamide | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
3-(hydroxyacetyl)indole | | indoles | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
n-(4-aminophenylsulfonyl)morpholine | | | | 2017 | 2017 | 7.0 | high | 0 | 0 | 0 | 0 | 1 | 0 |
1H-indol-3-yl-(4-methoxyphenyl)methanone | | N-acylindole | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-amino-5-phenyl-1,3,4-thiadiazole | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
N-(1-phenylethyl)acetamide | | acetamides; secondary carboxamide | | 2017 | 2017 | 7.0 | high | 0 | 0 | 0 | 0 | 1 | 0 |
alpha-(trichloromethyl)-4-pyridineethanol | | pyridines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
ml 204 | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
eudesmin | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
2-amino-4-methyl-3-nitropyridine | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
4,4-bis(hydroxymethyl)-2-phenyl-2-oxazoline | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
n-acetylhistidine | | histidine derivative; N-acetyl-amino acid | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1-(1-oxo-2-phenylethyl)-4-piperidinecarboxylic acid | | acetamides | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1-(4-chlorophenyl)-3-(2-ethoxyphenyl)urea | | ureas | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
4-methoxyxanthone | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
N-(4-nitrophenyl)-2-phenoxyacetamide | | C-nitro compound | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1-phenylindolin-2-one | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1-(benzenesulfonyl)indole | | sulfonamide | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
2,4,4,6-Tetramethyl-1,4-dihydro-3,5-pyridinedicarbonitrile | | dihydropyridine | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
pifithrin mu | | benzenes | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
2-benzyloxybenzaldehyde | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
2-guanidine-4-methylquinazoline | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
N-phenylcarbamic acid 2-phenoxyethyl ester | | carbamate ester | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
3,4-dihydro-2H-benzo[4,5]imidazo[2,1-b][1,3]thiazin-3-ol | | benzimidazoles | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
mequindox | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
N-[2-(dimethylamino)ethyl]-2,2-diphenylacetamide | | diarylmethane | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
Girgensonine | | nitrile | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
Dubinidine | | organic heterotricyclic compound; organonitrogen heterocyclic compound; oxacycle | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
N-[4-(methanesulfonamido)phenyl]acetamide | | sulfonamide | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
4-(2-oxazolo[4,5-b]pyridinyl)aniline | | 1,3-oxazoles | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-[(4-nitrophenyl)methylthio]-1,3-benzoxazole | | benzoxazole | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
3-oxido-4,5-dihydro-[1,2,5]oxadiazolo[3,4-f]cinnolin-3-ium | | pyridazines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
3-(2,4-difluoroanilino)-5,5-dimethyl-1-cyclohex-2-enone | | substituted aniline | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1-phenyl-4-pyrazolol | | pyrazoles; ring assembly | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
3-(3,5-dimethyl-1-pyrazolyl)-1,2-benzothiazole 1,1-dioxide | | benzothiazoles | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
3-benzamido-2-benzofurancarboxamide | | benzofurans | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-[2-(4-methoxyphenyl)ethyl]acetamide | | acetamides | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
N-[2-(3-methylphenoxy)ethyl]-1H-1,2,4-triazole-5-carboxamide | | aromatic ether | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-(1H-indol-3-ylthio)acetic acid | | indoles | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
3-bromo-N-[2-(4-nitroanilino)ethyl]benzamide | | carbonyl compound; organohalogen compound | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
3-Methylbenzofuran-2-carboxylic acid | | benzofurans | | 2017 | 2017 | 7.0 | high | 0 | 0 | 0 | 0 | 1 | 0 |
5-(3,4-dimethoxyphenyl)-2H-tetrazole | | tetrazoles | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1-(4-fluorophenyl)sulfonyl-4-(2-methoxyphenyl)piperazine | | piperazines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
4-[[bis(2-hydroxyethyl)amino]methyl]-2,6-ditert-butylphenol | | alkylbenzene | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-phenylindole-3-carbaldehyde | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
4-(2-pyridinylthio)benzofuro[3,2-d]pyrimidine | | aryl sulfide | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
5-(4-nitrophenyl)-4-phenyl-2-thiazolamine | | C-nitro compound | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
3-[6-(4-aminophenyl)-2-phenyl-4-pyrimidinyl]aniline | | pyrimidines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
7-methoxyisoflavone | | 7-methoxyisoflavones | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
LSM-32392 | | monoterpenoid | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-[2-(1-cyclohexenyl)ethyl]-4-(4-morpholinylmethyl)benzamide | | benzamides | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1-(1-benzimidazolyl)-3-(1-cyclohex-3-enylmethoxy)-2-propanol | | benzimidazoles | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-[2-(2-furanylmethylthio)ethyl]-4-methoxybenzenesulfonamide | | sulfonamide | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
3-acetamido-5-chloro-2-benzofurancarboxylic acid | | benzofurans | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]-(2,6-dimethoxyphenyl)methanone | | dimethoxybenzene | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
4-[4-methyl-6-(4-methyl-1-piperazinyl)-2-pyrimidinyl]morpholine | | N-arylpiperazine | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
haplamine | | organic heterotricyclic compound; organonitrogen heterocyclic compound; oxacycle | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
5-(3,4-dimethoxyphenyl)-1H-1,2,4-triazol-3-amine | | triazoles | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-ethoxy-N-[4-(4-morpholinylsulfonyl)phenyl]benzamide | | benzamides | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-[(5-methyl-1H-1,2,4-triazol-3-yl)thio]-1-phenylethanone | | aromatic ketone | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1-ethyl-6-methoxy-4-oxo-3-quinolinecarboxylic acid | | quinolines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-(pyridin-4-yl)-4-(pyrrolidin-1-yl)quinazoline | | pyridines; pyrrolidines; quinazolines | | 2017 | 2017 | 7.0 | high | 0 | 0 | 0 | 0 | 1 | 0 |
scp 1 | | | | 2017 | 2017 | 7.0 | high | 0 | 0 | 0 | 0 | 1 | 0 |
N-(3-acetamidophenyl)-4-methoxybenzamide | | benzamides | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-(3-acetamidophenyl)-3-chlorobenzamide | | benzamides | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
4-methoxy-N-(5-methyl-3-isoxazolyl)benzamide | | benzamides | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-(2-fluorophenyl)-4-phenylmethoxybenzamide | | benzamides | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-[4-(diethylamino)phenyl]-2-furancarboxamide | | aromatic amide; furans | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-(2-furanylmethyl)-2-benzofurancarboxamide | | benzofurans | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
5-(2-phenylethyl)-1,3,4-thiadiazol-2-amine | | aromatic amine; thiadiazoles | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
te 5 | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-[[anilino(oxo)methyl]amino]-4,5-dimethyl-3-thiophenecarboxamide | | ureas | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
N-(4,6-dimethyl-2-pyrimidinyl)-1,3-benzothiazol-2-amine | | benzothiazoles | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
6-methylflavone | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
2-methoxy-N-(2-pyridinyl)benzamide | | benzamides | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-chloro-N-(2-phenylethyl)benzamide | | carbonyl compound; organohalogen compound | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N1-(4H-1,2,4-triazol-4-yl)-4-nitrobenzamide | | C-nitro compound | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-[2-(1-cyclohexenyl)ethyl]-4-fluorobenzamide | | carbonyl compound; organohalogen compound | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
tioxazafen | | 1,2,4-oxadiazole; thiophenes | agrochemical; nematicide | 2017 | 2017 | 7.0 | high | 0 | 0 | 0 | 0 | 1 | 0 |
N-[5-(2-methylpropyl)-1,3,4-thiadiazol-2-yl]-2-thiophen-2-ylacetamide | | aromatic amide | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1-(4-Methoxyphenyl)-2-nitroethylene | | methoxybenzenes | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
brd32048 | | methoxybenzenes; substituted aniline | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-(4-chloro-3-methylphenoxy)-N-(1H-1,2,4-triazol-5-yl)acetamide | | aromatic ether | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-(3,4-dichlorophenyl)imidazo[1,2-a]pyrimidine | | imidazoles | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
5-(2-phenyl-4-triazolyl)-2H-tetrazole | | triazoles | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-cyclohexyl-2,3-dihydroindole-1-carboxamide | | indolyl carboxylic acid | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
4-(benzylsulfanyl)thieno[2,3-d]pyrimidine | | aryl sulfide; benzenes; thienopyrimidine | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
2-methyl-5-(5-methyl-2-furanyl)-3-(1-pyrrolyl)-4-thieno[2,3-d]pyrimidinone | | organic heterobicyclic compound; organonitrogen heterocyclic compound; organosulfur heterocyclic compound | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1-[2-(dimethylamino)ethyl]-5-methoxy-N-methyl-2-indolecarboxamide | | indolecarboxamide | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-(5-ethyl-1,3,4-thiadiazol-2-yl)-3-methoxybenzamide | | benzamides | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
4-(1H-benzimidazol-2-yl)quinoline | | quinolines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1-(4-Chlorophenyl)-2-[(1-methyl-1H-imidazol-2-yl)thio]ethan-1-one | | aromatic ketone | | 2017 | 2017 | 7.0 | high | 0 | 0 | 0 | 0 | 1 | 0 |
N-(2,5-dimethylphenyl)-2-benzofurancarboxamide | | aromatic amide; furans | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-(4-methoxyphenyl)-2-benzofurancarboxamide | | aromatic amide; furans | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-(9h-xanthen-9-yl)-malonic acid | | xanthenes | | 2017 | 2017 | 7.0 | high | 0 | 0 | 0 | 0 | 1 | 0 |
1-(1,3-benzothiazol-2-yl)-3-phenylurea | | ureas | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1-hydroxy-2-phenyl-1,5,6,7-tetrahydro-4H-benzimidazol-4-one | | imidazoles | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-(4-acetamidophenyl)-2-bromobenzamide | | benzamides | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
4-bromo-N-phenacylbenzamide | | aromatic ketone | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1-(2,3-dihydroindol-1-yl)-2-(phenylthio)ethanone | | indoles | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-[6-methyl-2-(4-methylphenyl)-5-benzotriazolyl]-3-pyridinecarboxamide | | triazoles | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N,N-dimethyl-N'-p-tolylsulfamide | | sulfamides | marine xenobiotic metabolite | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-(1-piperidinylmethyl)phenol | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2,6-bis(benzimidazol-2-yl)pyridine | | benzimidazoles | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
1-cyclohexyl-3-(2-phenylethyl)urea | | benzenes | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
1-(3,5-dichlorophenyl)-3-phenylurea | | ureas | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1-(cyclohexylmethyl)-4-phenylpiperazine | | piperazines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-phenethyl-2-furamide | | aromatic amide; heteroarene | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
paromomycin sulfate | | | | 2017 | 2017 | 7.0 | high | 0 | 0 | 0 | 0 | 1 | 0 |
N,N,2-trimethyl-1-phenyl-5-benzimidazolesulfonamide | | benzimidazoles | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-(phenylmethyl)-4-(3-pyridinyl)-2-thiazolamine | | aralkylamine | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-(4-hydroxy-2-methyl-5-propan-2-ylphenyl)benzenesulfonamide | | monoterpenoid | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-amino-5-ethyl-4-(2-furanyl)-6-propyl-3-pyridinecarbonitrile | | nitrile; pyridines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-ethoxy-N-[5-(methoxymethyl)-1,3,4-thiadiazol-2-yl]benzamide | | benzamides | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
vu0099704 | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
3-(4-chlorophenyl)-2,5-dimethyl-1H-pyrazolo[1,5-a]pyrimidin-7-one | | pyrazoles; ring assembly | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1-(2-chloro-6-fluorophenyl)-[1,2,4]triazolo[4,3-a]quinoline | | triazoles | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-methyl-N-(1-methyl-2,3-dihydropyrrolo[2,3-b]quinolin-4-yl)propanamide | | pyrroloquinoline | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-methyl-5-[(2-methyl-4-quinolinyl)thio]-1,3,4-thiadiazole | | aryl sulfide | | 2017 | 2017 | 7.0 | high | 0 | 0 | 0 | 0 | 1 | 0 |
5-methyl-1-(4-nitrophenyl)-2-oxo-2,5-dihydro-1h-pyrido(3,2-b)indole-3-carbonitrile | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
(3-hydroxy-5,6,7,8-tetrahydro-4H-cyclohepta[d]imidazol-2-yl)-phenylmethanone | | aromatic ketone | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-fluoro-N-phenacylbenzamide | | aromatic ketone | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
4-(methoxymethyl)-6-methyl-2-(2-methylanilino)-3-pyridinecarbonitrile | | nitrile; pyridines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1-azepanyl-[2-methoxy-4-(methylthio)phenyl]methanone | | carbonyl compound; thiol | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
GS4012 free base | | aryl sulfide; monomethoxybenzene; pyridines | VEGF activator | 2017 | 2017 | 7.0 | high | 0 | 0 | 0 | 0 | 1 | 0 |
N-[1-(4-methylphenyl)-5-benzimidazolyl]acetamide | | benzimidazoles | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-(4-methylanilino)-1-(4-nitrophenyl)ethanone | | aromatic ketone | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-(2,6-dimethylphenyl)-N(2)-(3,5-dimethylphenyl)glycinamide | | amino acid amide; glycine derivative | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-[4-[(3-fluorophenyl)methyl]-1-piperazinyl]pyrimidine | | N-arylpiperazine | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1-[(3,4-dimethoxyphenyl)methyl]-4-(2,3-dimethylphenyl)piperazine | | piperazines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
4-Piperidinobenzoic acid | | piperidines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1-(2-methoxyphenyl)-4-(3-thiophenylmethyl)piperazine | | piperazines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-(1-methyl-2,3-dihydropyrrolo[2,3-b]quinolin-4-yl)-2-(1-pyrrolidinyl)acetamide | | pyrroloquinoline | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
4-[(1H-benzimidazol-2-ylthio)methyl]-2-thiazolamine | | benzimidazoles | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
4-[(4-phenyl-2-thiazolyl)amino]benzenesulfonamide | | sulfonamide | | 2017 | 2017 | 7.0 | high | 0 | 0 | 0 | 0 | 1 | 0 |
N-[7-(1-oxopropyl)-2,3-dihydro-1,4-benzodioxin-6-yl]benzamide | | benzodioxine | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-[3-chloro-4-(1-pyrrolidinyl)phenyl]-2-furancarboxamide | | aromatic amide; furans | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
n-(pyridin-2-yl)-4-(pyridin-2-yl)thiazol-2-amine | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
8-(3,5-dimethyl-1-pyrazolyl)quinoline | | quinolines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2'-nitroflavone | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
N-(4-methoxyphenyl)-3,4-dihydroquinolin-2-amine | | aminoquinoline | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1-(3-nitrophenyl)-3-phenyl-2-propyn-1-one | | aromatic compound | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
vrt 532 | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
4-[[4-(2,5-dimethylphenyl)-1-piperazinyl]methyl]-2-methoxyphenol | | piperazines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1-piperonylpiperidine | | | | 2017 | 2017 | 7.0 | high | 0 | 0 | 0 | 0 | 1 | 0 |
2-[(3-fluorophenyl)methyl-(phenylmethyl)amino]ethanol | | aromatic amine | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-methoxy-4-[[2-(methylthio)anilino]methyl]phenol | | aromatic amine | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
6-ethyl-5-methyl-2-thiophen-2-yl-1H-pyrazolo[1,5-a]pyrimidin-7-one | | pyrazolopyrimidine | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-[4-(2-methyl-4-thiazolyl)phenyl]benzamide | | benzamides | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-(6-phenyl-5-imidazo[2,1-b]thiazolyl)benzamide | | imidazoles | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-(phenylmethylthio)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazole | | aryl sulfide | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
5-methyl-N-(4,5,6-trimethyl-2-pyrimidinyl)-1,3-benzoxazol-2-amine | | benzoxazole | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1-(4-methoxyphenyl)-3-(6-methyl-2-pyridinyl)urea | | ureas | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-{[hydroxy(2-methoxyphenyl)methylidene]amino}acetic acid | | N-acylglycine | | 2017 | 2017 | 7.0 | high | 0 | 0 | 0 | 0 | 1 | 0 |
(4-methoxyphenyl)-(3-methyl-2-propyl-4-imidazolyl)methanone | | aromatic ketone | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
N-(3-acetamidophenyl)-2-chlorobenzamide | | benzamides | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N4,N4-dimethyl-N1-(4-nitro-1,1-dioxo-2,5-dihydrothiophen-3-yl)benzene-1,4-diamine | | dialkylarylamine; tertiary amino compound | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-bromo-N-(3-methoxyphenyl)benzamide | | benzamides | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-methoxy-4-[(4-methyl-1,4-diazepan-1-yl)methyl]-6-nitrophenol | | aromatic ether; C-nitro compound | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
3-[[(2,5-dimethyl-3-furanyl)-oxomethyl]amino]benzoic acid | | aromatic amide; furans | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1-(4-ethoxyphenyl)-3-(6-quinoxalinyl)urea | | quinoxaline derivative | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-(dimethylsulfamoylamino)-9H-fluorene | | fluorenes | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
4-chloro-1-ethyl-3-nitro-2-quinolinone | | nitro compound; quinolines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
4-chloro-3-nitro-1-(phenylmethyl)-2-quinolinone | | quinolines | | 2017 | 2017 | 7.0 | high | 0 | 0 | 0 | 0 | 1 | 0 |
2,5-dimethyl-1-(phenylmethyl)pyrrole-3,4-dicarboxaldehyde | | arenecarbaldehyde | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-(2-chloro-6-fluorophenyl)-1-(2,4-dihydroxyphenyl)ethanone | | stilbenoid | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
4-methyl-N-(3-nitrophenyl)-5-phenyl-3-thiophenecarboxamide | | aromatic amide | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-(5-amino-1-phenyl-1,2,4-triazol-3-yl)-2,2,2-trichloroacetamide | | triazoles | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-(2-fluoro-5-methylphenyl)-3-phenylpropanamide | | anilide | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-[(4-fluorophenyl)methyl]-2-thiophen-2-ylacetamide | | organofluorine compound | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
4-tert-butyl-N-(1,4-dioxo-2,3-dihydrophthalazin-5-yl)benzamide | | phthalazines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-[2-(2-methylpropyl)-1,3-dioxo-5-isoindolyl]-2-furancarboxamide | | phthalimides | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
6-(1,4,5,7-tetramethyl-6-pyrrolo[3,4-d]pyridazinyl)quinoline | | quinolines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-(3,4-dimethoxyphenyl)-1-(2,4,6-trihydroxyphenyl)ethanone | | stilbenoid | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
5-(3-chloro-4-methylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole | | oxadiazole; ring assembly | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
5-(phenylmethyl)-3-(2-pyridinyl)-1,2,4-oxadiazole | | pyridines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-methyl-5-(1-pyrrolidinyl)isoindole-1,3-dione | | phthalimides | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
(2'-(4-aminophenyl)-(2,5'-bi-1h-benzimidazol)-5-amine) | | benzimidazoles | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
N-(4-bromo-2-fluorophenyl)-2-methyl-3-furancarboxamide | | aromatic amide; furans | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
6,7,8,9-tetrahydro-5H-carbazole-3-carbohydrazide | | carbazoles | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-(3-carbamoyl-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-2-pyrazinecarboxamide | | primary carboxamide; pyrazines; secondary carboxamide | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-(1,3-benzodioxol-5-yl)-5-methyl-2-furancarboxamide | | benzodioxoles | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1-cyclohexyl-3-(2,3-dihydro-1,4-benzodioxin-6-yl)urea | | benzodioxine | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
8-[(2-methyl-5-nitro-1,2,4-triazol-3-yl)thio]quinoline | | aryl sulfide | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1-[2-(2-chlorophenoxy)ethyl]benzimidazole | | benzimidazoles | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
4,5-dimethyl-2-[4-(3-nitrophenyl)-2-thiazolyl]-1H-pyrazol-3-one | | C-nitro compound | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-(4-fluoro-N-methylsulfonylanilino)-N-(3-methylphenyl)acetamide | | sulfonamide | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1-(4-fluorophenyl)-2-(2-pyridinylthio)ethanone | | aromatic ketone | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
3-methyl-6-(1-pyrrolidinyl)-[1,2,4]triazolo[4,3-b]pyridazine | | triazolopyridazine | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
N-(3-acetylphenyl)-2-thiophen-2-ylacetamide | | aromatic ketone | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
oncrasin-1 | | arenecarbaldehyde; indoles; monochlorobenzenes | antineoplastic agent; apoptosis inducer | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
N-[2-(4-fluorophenyl)ethyl]-4-nitrobenzamide | | C-nitro compound | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
5-(1-methyl-2-benzimidazolyl)-2-thiophenecarboxaldehyde | | benzimidazoles | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-(4-anilinophenyl)-2-methylpropanamide | | anilide | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-(2-fluorophenyl)-3-phenylpropanamide | | anilide | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1-[(Phenylthio)acetyl]piperidine | | N-acylpiperidine | | 2017 | 2017 | 7.0 | high | 0 | 0 | 0 | 0 | 1 | 0 |
N-(3-hydroxyphenyl)-5-methyl-3-furancarboxamide | | aromatic amide; furans | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
3-(4-methoxyphenyl)-5-(4-methylphenyl)-1,2,4-oxadiazole | | oxadiazole; ring assembly | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
4-[(4-carboxy-2,6-dimethoxyphenoxy)methyl]-5-methyl-2-furancarboxylic acid | | trihydroxybenzoic acid | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
4-(4-morpholinylmethyl)-3-quinolinol | | quinolines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-bromo-N-[3-(1-oxopropylamino)phenyl]benzamide | | benzamides | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
3-acetyl-2-methylbenzo[f]benzofuran-4,9-dione | | naphthofuran | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
5-(4-chlorophenyl)-N-(5-ethyl-1,3,4-thiadiazol-2-yl)-2-furancarboxamide | | aromatic amide; heteroarene | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1-azepanyl-[4-[(phenylthio)methyl]phenyl]methanone | | benzamides | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1-(5-ethyl-2,4-dihydroxyphenyl)-2-(2-fluorophenoxy)ethanone | | aromatic ketone | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-(2-nitrophenyl)acetamide | | acetamides | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
3,4,5-triethoxy-N-(1H-1,2,4-triazol-5-yl)benzamide | | benzamides | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1-propylsulfonyl-4-(2-pyridinyl)piperazine | | piperazines; pyridines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-(2-phenylethylthio)-3-pyridinecarboxylic acid | | aromatic carboxylic acid; pyridines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-(2,3-dimethylphenoxy)-N-pyridin-4-ylacetamide | | aromatic ether | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-[[anilino(oxo)methyl]amino]-N-(phenylmethyl)benzamide | | benzamides | | 2017 | 2017 | 7.0 | high | 0 | 0 | 0 | 0 | 1 | 0 |
N-(5-acetyl-4-methyl-2-thiazolyl)-5-bromo-2-furancarboxamide | | thiazoles | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1-cyclohexyl-3-(3-ethylphenyl)urea | | ureas | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
n-phenylpiracetam | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-[(1-methyl-5-tetrazolyl)thio]-N-(2-phenylphenyl)acetamide | | biphenyls | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-[3-chloro-4-(1-pyrrolidinyl)phenyl]-2-nitrobenzamide | | benzamides | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
4-(3,4-dihydro-1H-isoquinolin-2-ylmethyl)-N-(2,6-dimethylphenyl)benzamide | | isoquinolines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
5-(4-bromophenyl)-N-(2-methoxyphenyl)-2-furancarboxamide | | aromatic amide; furans | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
3-[[(3,5-dichloro-4-ethoxyphenyl)-oxomethyl]amino]benzoic acid | | benzamides | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1,4-bis(thiophen-2-ylsulfonyl)piperazine | | N-sulfonylpiperazine; thiophenes | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-bromo-N-[3-(1-oxobutylamino)phenyl]benzamide | | benzamides | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
1-(2-fluorophenyl)-4-[(6-nitro-1,3-benzodioxol-5-yl)methyl]piperazine | | piperazines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
n-(1-benzyl-4-piperidinyl)-2,4-dichlorobenzamide | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-[[2-(5-methyl-2-thiophenyl)-2-oxoethyl]thio]-3-phenyl-4-quinazolinone | | quinazolines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1-(2,1,3-benzothiadiazol-5-yl)-3-[4-(4-morpholinyl)phenyl]urea | | morpholines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
ethyl 4-{N-[(4-chlorophenyl)sulfonyl]-N-methylglycyl}piperazine-1-carboxylate | | carbamate ester; sulfonamide | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
LSM-4563 | | aromatic ketone | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1-(4-chloro-3-methoxyphenyl)sulfonyl-4-phenylpiperazine | | piperazines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-[4-[(3,4-dimethoxyphenyl)sulfamoyl]phenyl]acetamide | | sulfonamide | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
4-chloro-3-(1-piperidinylsulfonyl)-N-(2-thiazolyl)benzamide | | sulfonamide | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1-(2,5-dimethoxyphenyl)sulfonyl-4-(phenylmethyl)piperazine | | sulfonamide | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-(4-methoxyphenyl)-N-[4-[(5-methyl-3-isoxazolyl)sulfamoyl]phenyl]acetamide | | sulfonamide | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
4-[4-(benzenesulfonyl)-1-piperazinyl]-2-methylquinoline | | piperazines; pyridines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1-(6-methoxy-2,2,4-trimethyl-1-quinolinyl)-2-[[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]thio]ethanone | | quinolines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N2-phenyl-6-[[(1-phenyl-5-tetrazolyl)thio]methyl]-1,3,5-triazine-2,4-diamine | | tetrazoles | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-[(4,6-dimethyl-2-pyrimidinyl)thio]-N-(4,5-diphenyl-2-oxazolyl)acetamide | | 1,3-oxazoles | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-(4-bromophenyl)-1-[4-(2-pyridinyl)-1-piperazinyl]ethanone | | piperazines; pyridines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-amino[1,3]thiazolo[4,5-d]pyrimidine-5,7-diol | | thiazolopyrimidine | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
3-[[(2-cyclohexyl-1,3-dioxo-5-isoindolyl)-oxomethyl]amino]benzoic acid | | aromatic amide | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
3-[[[3-(1-azepanylsulfonyl)-4-chlorophenyl]-oxomethyl]amino]benzoic acid | | benzamides | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-(4-bromophenyl)-N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)acetamide | | acetamides | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
5-(1,3-benzodioxol-5-ylsulfamoyl)-2-methoxybenzoic acid | | methoxybenzoic acid | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-cycloheptyl-1-(4-methylphenyl)sulfonyl-4-piperidinecarboxamide | | sulfonamide | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
3-(2-chlorophenyl)-5-methyl-N-[4-[2-(4-morpholinyl)-2-oxoethoxy]phenyl]-4-isoxazolecarboxamide | | aromatic amide | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-[3-[[(4-nitrophenyl)-oxomethyl]amino]phenyl]-2-furancarboxamide | | benzamides | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
3-methyl-1,5-dithiophen-2-ylpentane-1,5-dione | | aromatic ketone | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-(2-methyl-1,3-benzothiazol-6-yl)-4-(4-morpholinylsulfonyl)benzamide | | sulfonamide | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
4-(dimethylsulfamoyl)-N-(4-thiophen-2-yl-2-thiazolyl)benzamide | | sulfonamide | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
3-chloro-N-[4-[(1-oxo-2-phenylethyl)amino]phenyl]benzamide | | benzamides | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-(3,4-dimethoxyphenyl)-4-[(4-phenyl-1-piperazinyl)methyl]benzamide | | benzamides | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
stk295900 | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1-(3-chlorophenyl)-4-[(3,4,5-trimethoxyphenyl)methyl]piperazine | | piperazines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-[4-[[4-(4-methoxyphenyl)-1-phthalazinyl]amino]phenyl]acetamide | | pyridazines; ring assembly | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1-(2-fluorophenyl)-3-[5-(2-fluorophenyl)-1,3,4-thiadiazol-2-yl]urea | | ureas | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-[5-[(4-methoxyphenyl)methyl]-1,3,4-thiadiazol-2-yl]-2-furancarboxamide | | methoxybenzenes | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-(1,3-benzodioxol-5-yl)-4-methyl-1-phthalazinamine | | phthalazines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
SMER 28 | | organobromine compound; quinazolines; secondary amino compound | autophagy inducer | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
N-[4-(4-morpholinyl)phenyl]carbamic acid butyl ester | | morpholines | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
4-(4-chlorophenoxy)-1-(4-morpholinyl)-1-butanone | | aromatic ether | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
4-(4-chlorophenoxy)-1-(1-piperidinyl)-1-butanone | | N-acylpiperidine | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-(3-phenylpropyl)methanesulfonamide | | benzenes | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
4-acetamido-N-(2-methoxyethyl)benzamide | | amidobenzoic acid | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-methyl-N-(2,3,4,5,6-pentafluorophenyl)-3-furancarboxamide | | aromatic amide; furans | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
3,4-dihydro-2H-quinolin-1-yl-(4-propoxyphenyl)methanone | | quinolines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
5-bromo-N-(2-phenylphenyl)-2-furancarboxamide | | aromatic amide; furans | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-[2-(4-chlorophenoxy)ethylthio]pyrimidine | | aromatic ether | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
3-(3-bromoanilino)-1-(5-methyl-2-furanyl)-1-propanone | | aralkylamine | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
4-[2-(4-bromo-2-chlorophenoxy)-1-oxoethyl]-1-piperazinecarboxylic acid ethyl ester | | piperazinecarboxylic acid | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-[2-[[3-(1,3-benzoxazol-2-yl)anilino]-oxomethyl]phenyl]benzoic acid | | benzamides | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1-[2-(2-chlorophenoxy)ethoxy]-2-methoxy-4-methylbenzene | | methoxybenzenes | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-[4-[(4-sulfamoylphenyl)sulfamoyl]phenyl]cyclopropanecarboxamide | | sulfonamide | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
4-[2-[2-(4-bromo-2-chlorophenoxy)ethoxy]ethyl]morpholine | | aromatic ether | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-[2-(2-phenylphenoxy)ethyl]-2-furancarboxamide | | biphenyls | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
5,6,7,8-tetrafluoro-2-(2,3,4,5,6-pentafluorophenyl)-4h-1-benzopyran-4-one | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-[bis(5-methyl-2-furanyl)methyl]-6-nitrophenol | | nitrophenol | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-(4-nitrophenyl)-N-(2-oxolanylmethyl)-4-quinazolinamine | | quinazolines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-(4-hydroxy-1,3-thiazol-2-yl)-1-phenylethan-1-one | | aromatic ketone | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
Methyl(2-furoylamino)acetic acid | | N-acyl-amino acid | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
5-nitro-8-(1-pyrrolidinyl)quinoline | | nitro compound; quinolines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-(3-oxo-2,4-dihydro-1H-quinoxalin-2-yl)-N-phenylacetamide | | amino acid amide | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-[(4-methylphenyl)sulfonylamino]pentanoic acid | | sulfonamide | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
4,6-dimorpholino-n-(4-nitrophenyl)-1,3,5-triazin-2-amine | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
1-[(3-chlorophenyl)methyl]-N,N-diethyl-3-piperidinecarboxamide | | piperidines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1-(2,6-dimethyl-1-piperidinyl)-2-phenylethanone | | acetamides | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-amino-7-methyl-5-oxo-4-(2,3,4-trimethoxyphenyl)-4,6,7,8-tetrahydro-1-benzopyran-3-carbonitrile | | methoxybenzenes | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
3-[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]-1-phenylpyrrolidine-2,5-dione | | pyrrolidines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1-(4-bromophenyl)-3-(diethylamino)pyrrolidine-2,5-dione | | pyrrolidines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
4-(5,6-diphenyl-1,2,4-triazin-3-yl)morpholine | | dialkylarylamine; tertiary amino compound | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
(3,5-Dimethyl-1-adamantyl)amine nitrate | | nitrates | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1-(4-tert-butylphenoxy)-3-(1H-1,2,4-triazol-5-ylthio)-2-propanol | | alkylbenzene | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-[2-(1-methyl-2-pyrrolidinyl)ethyl]-2-adamantanamine | | N-alkylpyrrolidine | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
4-phenyl-N-(pyridin-4-ylmethyl)-2-butanamine | | aralkylamine | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-(5-nitro-2-pyridinyl)cyclopropanecarboxamide | | aromatic amide | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
3-[(4-bromophenyl)methyl]-4-(4-methoxyanilino)-4-oxobutanoic acid | | anilide | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
3-ethyl-N-(2H-tetrazol-5-yl)-1-adamantanecarboxamide | | aromatic amide | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-(4-propan-2-ylphenyl)-3-bicyclo[2.2.1]heptanecarboxamide | | monoterpenoid | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
4-chloro-N-[2-(4-nitroanilino)ethyl]benzamide | | carbonyl compound; organohalogen compound | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-[(2,3-dihydro-1,4-benzodioxin-6-ylamino)-oxomethyl]-1-cyclohexanecarboxylic acid | | benzodioxine | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2,4-dichloro-6-[1-(4-morpholinyl)-3-phenylprop-2-ynyl]phenol | | aromatic compound | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-[[1-(4-ethoxyphenyl)-2,5-dioxo-3-pyrrolidinyl]amino]acetonitrile | | pyrrolidines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1-ethoxy-3-(2-methoxy-4-prop-2-enylphenoxy)-2-propanol | | methoxybenzenes | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
6-amino-4-(3-chlorophenyl)-3-methyl-1-(phenylmethyl)-4H-pyrano[2,3-c]pyrazole-5-carbonitrile | | organochlorine compound; pyranopyrazole | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1-(2-chlorophenoxy)-3-(2-methyl-1-benzimidazolyl)-2-propanol | | benzimidazoles | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-[2-furanyl-(8-hydroxy-7-quinolinyl)methyl]-2-methylpropanamide | | hydroxyquinoline | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-(2-hydroxy-5-methylphenyl)-2-furancarboxamide | | aromatic amide; furans | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
4-amino-7,8,9,10-tetrahydro-6H-pyrimido[3,4]pyrrolo[3,5-a]azepine-11-carbonitrile | | organic heterobicyclic compound; organonitrogen heterocyclic compound | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1-(3,5-dimethylphenyl)-3-(1H-1,2,4-triazol-5-ylthio)pyrrolidine-2,5-dione | | pyrrolidines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
6-[(3,4-difluoroanilino)-oxomethyl]-1-cyclohex-3-enecarboxylic acid | | anilide | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
4-[(3-cyano-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophen-2-yl)amino]-4-oxobutanoic acid | | organosulfur heterocyclic compound | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
[3-methyl-4-[oxo(thiophen-2-yl)methyl]-1-piperazinyl]-thiophen-2-ylmethanone | | aromatic amide; thiophenes | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
[4-(2-methoxyphenyl)-1-piperazinyl]-[4-[(phenylthio)methyl]phenyl]methanone | | piperazines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-(3,3,5-trimethylcyclohexyl)-1H-1,2,4-triazole-5-carboxamide | | aromatic amide; heteroarene | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
4-[2-nitro-5-[4-(phenylmethyl)sulfonyl-1-piperazinyl]phenyl]morpholine | | piperazines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
5-(4-ethylsulfonyl-1-piperazinyl)-2-nitro-N-(3-pyridinylmethyl)aniline | | piperazines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-[[5-[(1,3-benzothiazol-2-ylthio)methyl]-4-methyl-1,2,4-triazol-3-yl]thio]-N-[2-(4-morpholinyl)ethyl]acetamide | | benzothiazoles | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-ethyl-N-[2-[(5-nitro-8-quinolinyl)amino]ethyl]benzenesulfonamide | | nitro compound; quinolines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1-(4-methoxyphenyl)-N-(4-methyl-2-pyridinyl)-5-oxo-3-pyrrolidinecarboxamide | | pyrrolidines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
3,4,5-trimethoxy-N-[4-[(2-methyl-1-piperidinyl)sulfonyl]phenyl]benzamide | | benzamides | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
3-(n,n-dimethylsulfonamido)-4-methyl-nitrobenzene | | C-nitro compound; sulfonamide; toluenes | bone density conservation agent; EC 3.1.4.53 (3',5'-cyclic-AMP phosphodiesterase) inhibitor; geroprotector | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
6,3',4'-Trimethoxyflavanone | | ether; flavonoids | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
1-[4-(3-ethoxyphenoxy)butyl]imidazole | | aromatic ether | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
5-[[(1-cyclohexyl-5-tetrazolyl)thio]methyl]-3-phenyl-1,2,4-oxadiazole | | oxadiazole; ring assembly | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-[1-(3,4-dihydro-2H-quinolin-1-yl)-1-oxopropan-2-yl]isoindole-1,3-dione | | phthalimides | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
[4-(benzenesulfonyl)-1-piperazinyl]-(1-piperidinyl)methanone | | sulfonamide | | 2017 | 2017 | 7.0 | high | 0 | 0 | 0 | 0 | 1 | 0 |
3-(2,5-dioxo-1-pyrrolidinyl)-N-(2-methyl-1,3-dioxo-5-isoindolyl)benzamide | | amidobenzoic acid | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
6-[[[5-(ethylthio)-1,3,4-thiadiazol-2-yl]amino]-oxomethyl]-1-cyclohex-3-enecarboxylic acid | | aromatic amide | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2,5-dimethoxy-n-(quinolin-3-yl)benzenesulfonamide | | quinolines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
LSM-25805 | | isoindoles | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
4-ethoxy-N-(3-quinolinyl)benzenesulfonamide | | quinolines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
3-chloro-N-[3-(1-imidazolyl)propyl]-6-nitro-1-benzothiophene-2-carboxamide | | 1-benzothiophenes | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
nsc 727447 | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
2-(4-chlorophenoxy)-N-(5-nitro-2-thiazolyl)acetamide | | C-nitro compound; thiazoles | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
7-(2-methoxyphenyl)-5-phenyl-1,7-dihydrotetrazolo[1,5-a]pyrimidine | | methoxybenzenes | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-[3-[2,5-dioxo-3-(phenylmethyl)-1-pyrrolidinyl]phenyl]acetamide | | pyrrolidines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
3,4-dimethoxy-N-[3-(methylthio)phenyl]benzenesulfonamide | | sulfonamide | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
3-methyl-4-nitro-N-(1H-1,2,4-triazol-5-yl)benzamide | | C-nitro compound | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-[(4-chlorophenyl)methylthio]-N-(2-hydroxy-5-nitrophenyl)acetamide | | nitrophenol | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-(4-ethoxyphenyl)-N-[3-(1-imidazolyl)propyl]-4-quinolinecarboxamide | | quinolines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N-(4-bromophenyl)-5-methyl-4-nitro-1H-pyrazol-3-amine | | C-nitro compound | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
3,3-bis(4-hydroxyphenyl)-7-methyl-1,3-dihydro-2h-indol-2-one | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
N-[4-[(cyclohexylamino)-oxomethyl]phenyl]-3-pyridinecarboxamide | | aromatic amide | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
N,N,4-trimethyl-2-[[(5-methyl-2-furanyl)-oxomethyl]amino]-5-thiazolecarboxamide | | aromatic amide; thiazoles | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
ex 527 | | carbazoles; monocarboxylic acid amide; organochlorine compound | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
3-[3-[(5-ethyl-[1,2,4]triazino[5,6-b]indol-3-yl)thio]propyl]-1H-benzimidazol-2-one | | indoles | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
4-methyl-2,7-diphenyl-8H-pyrido[2,3-d]pyrimidin-5-one | | phenylpyridine | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
3-methylharman | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
1-methyl-beta-carboline-3-carboxylic acid | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
sildenafil | | piperazines; pyrazolopyrimidine; sulfonamide | EC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor; vasodilator agent | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
2-methyl-4(3h)-quinazolinone | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
n(4)-desoxychlordiazepoxide | | | | 2017 | 2017 | 7.0 | high | 0 | 0 | 0 | 0 | 1 | 0 |
2-amino-3-hydroxyphenazine | | | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
2-styrylquinazolin-4(3h)-one | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
2-amino-5-iodo-6-phenyl-4-pyrimidinone | | | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
quininib | | phenols; styrylquinoline | angiogenesis inhibitor | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
bropirimine | | pyrimidines | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
2-[(6-ethyl-4-methyl-2-quinazolinyl)amino]-1H-quinazolin-4-one | | quinazolines | | 2017 | 2017 | 7.0 | high | 0 | 0 | 0 | 0 | 1 | 0 |
2-[(6-ethyl-4-methyl-2-quinazolinyl)amino]-6-(methoxymethyl)-1H-pyrimidin-4-one | | quinazolines | | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |